Promising New Target for High-Grade Pediatric Gliomas

Promising New Target for High-Grade Pediatric Gliomas

Source: Inside Precision Medicine

The team provided clinical data to support the use of a PDGFRA inhibitor (avapritinib/Blueprint Medicines' Ayvakit) in the treatment of certain pediatric patients with high-grade gliomas.

Platelet-derived growth factor receptor alpha (PDGFRA) is a potential new drug target for pediatric high-grade gliomas, according to research from Dana Farber and collaborators. The team also provided the first real-world clinical data to support the… [3206 chars]

Read more